Abstract
Sutherlandia frutescens is a medicinal plant, indigenous to South Africa, used to treat a number of conditions, including Type 2 Diabetes (T2D) and immune disorders. It is thought to have the capacity to regulate macrophage differentiation, thus impacting upon metabolic immune diseases and indicating a potential for ethnopharmaceutical use. In this paper we report the molecular action of S. frutescens with regard to in vitro macrophage differentiation and potential functions in vivo involving inflammation and wound healing.The responses of cells of the RAW 264.7 murine macrophage cell line (a model for macrophage function) to hot aqueous or 100% ethanol extracts of S. frutescens prepared from a single plant source previously shown to target T2D were compared to determine the relative efficacy and action of each extract. Activation of the pro-inflammatory M1 phenotype and the anti-inflammatory M2 phenotype was investigated using the CD markers CD86 (M1) and CD206 (M2). Both S. frutescens extracts down-regulated CD86 expression, and the ethanolic extract up-regulated CD206, indicating stimulation of the M2 phenotype over the M1 phenotype. M1 macrophage pro-inflammatory responses in vitro, including nitric oxide and reactive oxygen species production and cyclo-oxygenase-2 (COX-2) expression were inhibited by both extracts. This is the first report of down regulation by S. frutescens of COX-2, a major pro-inflammatory mediator. Patterns of cytokine production determined by ELISA assays, showed down-regulation of the M1 pro-inflammatory cytokine profile, whilst the M2 cytokine profile remained unchanged. Reduced production of inflammatory mediators was associated with decreased activity of the mitogen activated protein kinases (MAPKs) and nuclear factor kappa-light-chain-enhancer of activated B-cells (NFKB) signalling pathways. This novel finding in an in vitro model of macrophage responses to S. frutescens leads to the hypothesis that several medicinal properties of S. frutescens extracts are mediated by regulation of MAPK and NFKB cell signaling pathways leading to a reduction in M1 macrophage activity and redirection towards M2 anti-inflammatory functions, thus promoting tissue remodeling and immune regulation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
